Cytovant

China
Shaxi, Fujian, China, 201203

Company profile

Cytovant company profile

Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics. The company focuses on developing modified T-cell receptor therapeutics and dendritic cell vaccines that target tumor antigens to improve tumor cells therapy and treatment.

Business identity

Contact email
[email protected]
Phone number
+86 21 5090 0866
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2019-04-01, Month

Headquarters

Postal code
201203
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$23.5M
Last funding
Series Unknown / $23.5M / 2020-04-03
Last equity funding
Series Unknown / $23.5M
Investors
4
Lead investors
1
Founders
1

Founders and investors

Founders

Xinan Chen

Lead investors

BNH

Investors

BNHMirae Asset Venture InvestmentPOSCO Venture CapitalSmilegate Investment